Enfermedades Infecciosas y Microbiología Clínica (English Edition)
Download PDF
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Impact of nirsevimab immunization on admissions at a tertiary hospital
Manuel Oltra-Benavent; Raquel Suay-Romero; Eva Muro-Díaz; Pablo Javier Taberner-Pérez; María Belén Ferrer-Lorente; Juan Pablo Ferrer-González; María Garcés-Sánchez;
Enferm Infecc Microbiol Clin. 2026;44:
Comparative analysis of acute respiratory infections of viral etiology in children under 6 months with and without nirsevimab in the Balearic Islands (2022–2023 and 2023–2024)
Jordi Reina; Ane Iturbe; Julia Viana-Ramírez; Guida Sbert; Jaume Carrasco; Joaquín Dueñas;
Enferm Infecc Microbiol Clin. 2025;43:193-6
Impact of the passive immunization campaign with nirsevimab in 2023–24 in Castellón. Final results
Eulalia Gregori-García; Juan Carlos Gascó-Laborda; Lledó Lluch-Bacas; Oscar Pérez-Olaso; Iris Gómez-Alfaro; Juan B. Bellido-Blasco;
Enferm Infecc Microbiol Clin. 2025;43:215-8